Teva, Comcast, Steve Madden, MIFA: Intellectual Property

Updated on

Teva Pharmaceutical Industries Ltd. got a mixed reception at a U.S. Supreme Court hearing as the company sought to preserve a patent shielding its top-selling Copaxone multiple-sclerosis drug from generic competition.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.